Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of evocalcet in secondary hyperparathyroidism
NCT02549404Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP7991 in secondary hyperparathyroidism (SHPT), sponsored by Kyowa Kirin. Started Sep 2015; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02549404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549404.